Clinical Trials Browser

Phase 3 × Amyloidosis × Plasma cell × Clear all

NCT01078454 2022-02-01

Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis

Phase 3 Completed

11 enrolled 6 charts

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT01277016 2017-03-10

EMN-03

Phase 3 Completed

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT01998503 2013-11-29

Bortezomib and Dexamethasone Followed by ASCT Compared With ASCT Alone in Treating Patients With AL Amyloidosis

Phase 3 Completed

Immunoglobulin Light-chain Amyloidosis, Amyloidosis